UPCI CANCER SERVICES H-1B Visa Sponsorship & Salary Data

The median H-1B salary at UPCI CANCER SERVICES is $189,114, based on 28 certified filings from FY 2020 to FY 2026. This is 58% higher than the national H-1B median salary of $120,000. Compensation at UPCI CANCER SERVICES reflects their market positioning, with entry-level roles starting around $150,052 and senior positions reaching $212,629 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at UPCI CANCER SERVICES range from $123,118 at the 10th percentile to $212,629 at the 90th percentile, showing a $89,511 spread across experience levels and roles. The 25th percentile is $150,052 and the 75th percentile is $207,698.

Yes, UPCI CANCER SERVICES actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 29 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 28 certified applications and a 0% denial rate, UPCI CANCER SERVICES maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), UPCI CANCER SERVICES filed 4 H-1B applications, with 4 certified and 0 denied. Over 6 years of data, UPCI CANCER SERVICES has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

UPCI CANCER SERVICES's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 29 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating UPCI CANCER SERVICES as a potential H-1B sponsor.

This is an excellent approval rate, indicating UPCI CANCER SERVICES has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

UPCI CANCER SERVICES sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 28 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles UPCI CANCER SERVICES most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at UPCI CANCER SERVICES:

The most frequently sponsored role is Medical Physicist with 14 filings at a median salary of $189,114. This is followed by Physicist (7 filings) and Senior Medical Dosimetrist.

UPCI CANCER SERVICES's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where UPCI CANCER SERVICES sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top UPCI CANCER SERVICES H-1B locations:

The largest H-1B hub for UPCI CANCER SERVICES is Pittsburgh, PA with 16 filings at a median salary of $191,006. The highest-paying location is Greensburg, PA at $212,629 median. Salaries range from $120,016 to $212,629 across office locations.

UPCI CANCER SERVICES's median H-1B salary has increased by +9% from FY 2020 ($194,792) to FY 2026 ($212,629). Tracking salary trends over time reveals how UPCI CANCER SERVICES adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at UPCI CANCER SERVICES.

Year-by-year breakdown:

• FY 2021: $186,120 (1 certified)
• FY 2022: $207,698 (5 certified)
• FY 2023: $158,688 (5 certified)
• FY 2025: $156,399 (5 certified)
• FY 2026: $212,629 (4 certified)

UPCI CANCER SERVICES has maintained steady salary growth for H-1B positions over this period.

UPCI CANCER SERVICES primarily files H-1B applications at Wage Level IV, accounting for 71% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making UPCI CANCER SERVICES's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, UPCI CANCER SERVICES typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

UPCI CANCER SERVICES's median H-1B salary of $189,114 is 58% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating UPCI CANCER SERVICES's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare UPCI CANCER SERVICES's offerings with similar companies in your field for a more accurate assessment.

This places UPCI CANCER SERVICES among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. UPCI CANCER SERVICES's higher proportion of Level III-IV positions (96%) may benefit from wage-based lottery prioritization.

With 28 certified filings, UPCI CANCER SERVICES invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.